CTi's Strategic Agreement with Desmet Belgium
Cavitation Technologies, Inc. (CTi), a notable player in innovative flow-through nano-technology systems, has made a significant move to strengthen its financial and operational foundation. In a recent agreement with Desmet Belgium S.A., CTi aims to monetize parts of its intellectual property portfolio while maintaining critical licenses that will support its ongoing business activities.
Details of the Agreement
The deal entails CTi transferring several patents and related technical information to Desmet. This collaboration highlights CTi's strategy to leverage its intellectual property effectively. Notably, the patents will primarily relate to applications in the vegetable oil and fats sector. Additionally, the Company will assign two of its U.S. trademark registrations—specifically for the Nano Neutralization® and Nano Reactor® marks—to Desmet.
Retaining Essential Licenses
A key component of this agreement is that CTi will retain a worldwide, exclusive, royalty-free license for the patent technology. This provision ensures that CTi can continue to utilize and enhance its processes in other important fields such as water processing and alcoholic beverage production. By holding onto these rights, CTi can innovate and expand within its primary business lines without restrictions from the patent transfer.
Leadership Insights
Neil Voloshin, CEO of CTi, commented positively on this strategic transaction. He conveyed that this move would not only enable CTi to unlock the value of its existing IP but also provide necessary capital to support the company’s growth plans. Voloshin emphasized the non-dilutive nature of this transaction, reassuring stakeholders that their shares would remain unaffected while the company continues to develop business partnerships.
Implications for CTi's Future
This strategic partnership with Desmet is poised to enhance CTi's operational capabilities. As the transaction progresses, CTi will carry out the necessary assignment documentation, expected to finalize within a short timeframe. This agility demonstrates CTi’s commitment to improving its operational efficiency while fortifying its market position.
About Desmet Belgium S.A.
Desmet stands out as a leading global provider of engineered solutions for various sectors, including food and biofuels. With 75 years of experience, Desmet specializes in transforming raw materials into products that meet the demands of a sustainable future. Their extensive expertise positions them as a key partner for CTi, further solidifying the utility of the intellectual properties involved in this agreement.
Cavitation Technologies, Inc. Overview
Founded in 2007, Cavitation Technologies, Inc. focuses on developing innovative systems for fluid processing applications. Its proprietary Nano Reactor® technology underscores its dedication to sustainability and efficiency across industries ranging from water treatment to food production. With over 40 patents filed, CTi's commitment to research and development ensures a forward-looking approach to technological advancement.
Recent Developments
CTi has been active in enhancing its range of innovative technology solutions to meet current market needs. The company is continuously exploring avenues for growth through strategic partnerships such as the one with Desmet, aiming to integrate and optimize different applications of its technology in various sectors. As CTi progresses, stakeholders can anticipate exciting developments that reflect the company's commitment to being at the forefront of technology innovation.
Frequently Asked Questions
What is the purpose of the agreement between CTi and Desmet?
The agreement aims to monetize CTi's intellectual property portfolio while allowing the company to retain essential licenses for its core business operations.
How will CTi benefit from this transaction?
CTi will unlock the value of its patents and trademarks, providing substantial capital, while maintaining exclusive rights for using the technology in specific fields.
What does the deal involve in terms of patents and trademarks?
CTi will transfer certain U.S. and non-U.S. patents and trademarks to Desmet while retaining licenses to use the technology in several key areas.
Who is the CEO of Cavitation Technologies, Inc.?
Neil Voloshin is the CEO of Cavitation Technologies, Inc., and he has expressed optimism regarding this agreement's implications for the company's future.
What industries does Cavitation Technologies, Inc. serve?
CTi serves various industries, including edible oil refining, renewable fuel production, water treatment, and alcoholic beverage enhancement through its innovative technologies.
